TURTLE CAMERON (Chief Executive Officer) sold 6.0% of their position (45K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.05M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/5/2025ACC: 0001636282-25-000106
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-45K
Net shares
Net seller
$1.05M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−28.16K
Price / share
$23.13
Trade value
$651.23K
% of position
3.8%
11/3/2025
746.91K→718.75K
Common Stock
Direct
Shares
−16.84K
Price / share
$23.66
Trade value
$398.55K
% of position
2.3%
11/3/2025
718.75K→701.91K
Total
Net shares
−45K
Net value
-$1.05M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/3/2025 | S · Sale | −28.16K | $23.13 | $651.23K | 3.8% | 746.91K | 718.75K |
| Common Stock Direct | 11/3/2025 | S · Sale | −16.84K | $23.66 | $398.55K | 2.3% | 718.75K | 701.91K |
| Total | −45K | -$1.05M | ||||||
Derivative Transactions0
No derivative transactions reported